What can be done for patients with NSCLC without druggable targets?

Lancet Oncol. 2013 Mar;14(3):191-2. doi: 10.1016/S1470-2045(13)70018-4.
No abstract available

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • ErbB Receptors / genetics
  • Genome, Human
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Molecular Targeted Therapy*
  • Receptor Protein-Tyrosine Kinases / genetics

Substances

  • Anaplastic Lymphoma Kinase
  • EGFR protein, human
  • ErbB Receptors
  • Receptor Protein-Tyrosine Kinases